Human cDNAs and proteins and uses thereof

Details Human cDNAs and proteins and uses thereof Human cDNAs and proteins and uses thereof

2007-10-23

2007-10-23

Martinell, James (Department: 1634)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Reexamination Certificate

active

10485231

ABSTRACT:
The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.

REFERENCES:
patent: 4902505 (1990-02-01), Pardridge et al.
patent: 4987084 (1991-01-01), Tedder et al.
patent: 5229494 (1993-07-01), Evans et al.
patent: 5445942 (1995-08-01), Rabin et al.
patent: 5595721 (1997-01-01), Kaminski et al.
patent: 5599400 (1997-02-01), Mao et al.
patent: 5641670 (1997-06-01), Treco et al.
patent: 5693496 (1997-12-01), Alves et al.
patent: 5714459 (1998-02-01), O'Brien et al.
patent: 5762926 (1998-06-01), Gage et al.
patent: 5840688 (1998-11-01), Tso
patent: 5932536 (1999-08-01), Wright et al.
patent: 5948756 (1999-09-01), Barenholz et al.
patent: 5952034 (1999-09-01), Buchanan et al.
patent: 5989545 (1999-11-01), Foster et al.
patent: 6004554 (1999-12-01), Thorpe et al.
patent: 6027935 (2000-02-01), Purchio et al.
patent: 6074844 (2000-06-01), Hillman et al.
patent: 6090631 (2000-07-01), Catterall et al.
patent: 6099857 (2000-08-01), Gross
patent: 6110747 (2000-08-01), Blaschuk et al.
patent: 6113951 (2000-09-01), Buchanan et al.
patent: 6117454 (2000-09-01), Kreuter et al.
patent: 6153192 (2000-11-01), Kopetzki et al.
patent: 6169074 (2001-01-01), Montal et al.
patent: 6180602 (2001-01-01), Kato et al.
patent: 6190723 (2001-02-01), Buchanan et al.
patent: 6191154 (2001-02-01), Landreth et al.
patent: 6197940 (2001-03-01), Klinefelter
patent: 6268487 (2001-07-01), Kutzko et al.
patent: 2003/0118997 (2003-06-01), Bejanin et al.
patent: 1033401 (2000-09-01), None
patent: WO97/07198 (1997-02-01), None
patent: WO98/14581 (1998-04-01), None
patent: WO98/56818 (1998-12-01), None
patent: WO99/02171 (1999-01-01), None
patent: WO99/24565 (1999-05-01), None
patent: WO99/38963 (1999-08-01), None
patent: WO 00/55632 (2000-09-01), None
patent: WO 01/51618 (2001-07-01), None
Albertin, G. et al., “Cerebellin stimulates the secretory activity of the rat adrenal gland: in vitro and in vivo studies”,Neuropeptides(2000), 34:7-11; INIST CNRS.
Biber, K. et al., Ischemia-Induced Neuronal Expression of the Microglia Attracting Chemokine Secondary Lymphoid-Tissue Chemokine (SLC),GLIA(2001), 34:121-133; INIST CNRS.
Braun, S. et al., “The CC Chemokine CKβ/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK Cells”,J. Immunol(2000), 164:4025-31; The American Association of Immunologists.
Brem, H. et al. “Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas”,J. Neurosurg.(1991), 74:441-446; INIST CNRS.
Bronson, R. et al., “Sperm antibodies: their role in infertility”,Fertil and Steril(1984), 42:171-83; The American Fertility Society.
Bunn Jr., P. et al., “Imaging of T-Cell Lymphoma by Radiolabelled Monoclonal Antibody”,Lancet(1984), 2:1219-21.
Cella, M. et al., “A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing”,J. Exp. Med.(1997), 185(10):1743-1751; The Rockefeller University Press.
Chee, M. et al., “Accessing Genetic Information with High-Density DNA Arrays”,Science(1996), 274:610-614.
Dialynas, D. et al., Preconditioning with fetal cord blood facilities engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice,Blood(2001), 97(10):3218-25; The American Society of Hematology.
Dieu-Nosjean, M.-C., et al., “Regulation of the dendritic cell trafficking: a process that involves the participation of selective chemokines”,J. Leukoc. Biol.(1999); 66:252-62; INIST CNRS.
Gosling, J. et al., “Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK”,J. Immunol.(2000), 164:2851-6; The American Association of Immunologist.
Gunn, M. et al., “Mice Lacking Expression of Secondary Lymphoid Organ Chemokine Have Defects in Lymphocyte Homing and Denkritic Cell Localization” ,J. Exp. Med.(1999), 189(3):451-460.
Gunn, M. et al., “A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naïve T lymphocytes”,Proc. Natl. Acad. Sci. USA(1998), 95:258-263.
Hiraiwa, M. et al., “Binding and transport of gangliosides by prosaposin”,Proc. Natl. Acad. Sci. USA(1992), 89:11254-11258.
Hjelmström, P. et al., “Lypmhoid Tissue Homing Chemokines Are Expressed in Chronic Inflammation”,American Journal of Pathology(2000), 156(4):1133-8.
Kaneda, Y. et al., “Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver”,Science(1989), 243:375-8.
Kennedy, J.H. et al., “Protein-Protein Coupling Reactions and the Applications of Protein Conjugates”,Clin. Chim. Acta(1976), 70:1-31; Elsevier Scientific Publishing Company, Amsterdam, Holland.
Kim, C. et al., “SLC/Exodus2/6Ckine/TCA4 induces chemotaxis of hemopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation”,J. Leukoc. Biol.(1999), 66:455-61.
Kirk, C. et al., “T Cell-dependent Antitumor Immunity Mediated by Secondary Lymphoid Tissue Chemokine: Augmentation of Dendritic Cell-based Immunotherapy”,Cancer Research(1999), 61:2062-70.
Loechel. F. et al., “Human ADAM 12 (Meltrin α) Is an Active Metalloprotease”,J. Biol. Chem.(1998), 273:16993-7; The American Society for Biochemistry and Molecular Biology, Inc.
Loeffen, J. et al., “The human NADH:ubiquinone oxidoreductase NDUFS5 (15kDa) subunit: cDNA cloning, chromosomal localization, tissue distribution and the absence of mutations in isolated complex I-deficient patients”,J. Inher. Metab. Dis.(1999), 22:19-28; SSIEM and Kluwer Academic Publishers, Holland.
Machens, H.-G. et al., “Bioartificial Skin”,Cells Tissues Organs(2000), 167:88-94; INIST CNRS.
Marg, A. et al., “Neurotractin, A Novel Neurite Outgrowth-promoting Ig-like Protein that Interacts with CEPU-1 and LAMP”,J. Cell Biol.(1999), 145:865-876; The Rockefeller University Press.
Medley, Q., et al., “Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition”,Proc. Natl. Acad. Sci. USA(1996), 93:685-689.
Melton, R., et al., “Antibody-Enzyme Conjugates for Cancer Therapy”,J. Natl. Cancer Inst.(1996) 88(3/4):153-65; INIST CNRS.
Miyachi, K. et al., “Autoantibody to a Nuclear Antigen in Proliferating Cells”,J. Immunol.(1978), 121(6):2228-34; The Williams & Wilkins Co.
Morimoto, S. et al., “Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases”,Proc. Natl. Acad. Sci. USA(1990), 87:3493-3497.
Mulligan, R. “The Basic Science of Gene Therapy”,Science(1993), 260:926-32.
Murphy, P. et al., “International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors”,Pharmacological Reviews(2000), 52(1):145-176.
Nagira, M. et al., “Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13”,J. Biol. Chem.(1997), 272(31):19518-24.
Nagira, M. et al., “Enhanced HIV-1 Replication by Chemokines Constitutively Expressed in Secondary Lymphoid Tissues”,Virology(1999), 264:422-426, INIST CNRS.
Nomura, T. et al., “Enhancement of Anti-Tumor Immunity by Tumor Cells Transfected with the Secondary Lymphoid Tissue Chemokine EBI-1-Ligand Chemokine and Stromal Cell-Derived Fa

Affiliated with

Also associated with

Rating

Human cDNAs and proteins and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human cDNAs and proteins and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human cDNAs and proteins and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3902741